zoom_in
Click to enlarge
description Amgen (AMGN) Overview
Amgen is a leading biotechnology company focused on developing and manufacturing innovative medicines. The company's portfolio includes therapies for serious illnesses. Amgen has a history of dividend increases and is committed to shareholder returns. Its research and development pipeline aims to drive future growth.
The current dividend yield is approximately 3.1%.
help Amgen (AMGN) FAQ
What is Amgen (AMGN)?
Amgen is a leading biotechnology company focused on developing and manufacturing innovative medicines. The company's portfolio includes therapies for serious illnesses. Amgen has a history of dividend increases and is committed to shareholder returns. Its research and development pipeline aims to drive future growth. The current dividend yield is approximately 3.1%.
How good is Amgen (AMGN)?
Amgen (AMGN) scores 7.8/10 (Good) on Lunoo, making it a well-rated option in the Dividend Stocks category.
What are the best alternatives to Amgen (AMGN)?
See our alternatives page for Amgen (AMGN) for a ranked list with scores. Top alternatives include: Johnson & Johnson (JNJ), Medtronic (MDT), NextEra Energy (NEE).
How does Amgen (AMGN) compare to Johnson & Johnson (JNJ)?
See our detailed comparison of Amgen (AMGN) vs Johnson & Johnson (JNJ) with scores, features, and an AI-powered verdict.
Is Amgen (AMGN) worth it in 2026?
With a score of 7.8/10, Amgen (AMGN) is a solid option in Dividend Stocks. See all Dividend Stocks ranked.
explore Explore More
Similar to Amgen (AMGN)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
